Pharmacoeconomics of Clozapine, Risperidone and Olanzapine: A Review of the Literature

ISSN： 1172-7047

Source： CNS Drugs, Vol.13, Iss.1, 2000-01, pp. : 47-76

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clozapine/olanzapine/risperidone: Paralytic ileus (first report with olanzapine and risperidone): case report

Reactions Weekly, Vol. 1, Iss. 1151, 2007-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Clozapine/olanzapine/risperidone: Weight gain treated with topiramate: 3 case reports

Reactions Weekly, Vol. 1, Iss. 1088, 2006-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Effectiveness and Cost of Risperidone and Olanzapine for Schizophrenia: A Systematic Review

By Hargreaves William A.

CNS Drugs, Vol. 19, Iss. 5, 2005-01 ,pp. : 393-410

Adis International

Access to resources Recommend Favorite

Pharmacoeconomics for the Pharmaceutical Industry in Europe: A Literature Review

By Zikopoulos A.

International Journal of Pharmaceutical Medicine, Vol. 17, Iss. 5-6, 2003-01 ,pp. : 201-209

Adis International

Access to resources Recommend Favorite

Olanzapine: a critical review of recent literature

By Buckley Peter F

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 12, 2005-10 ,pp. : 2077-2089

Informa Healthcare

Access to resources Recommend Favorite